Diabetes treatment is constantly progressing, with new therapeutic options developing to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the https://kathrynwefy032746.wssblogs.com/38937380/promising-glp-1-and-gip-receptor-agonists-a-new-era-in-diabetes-treatment